M.L. Williams

1.2k total citations
37 papers, 501 citations indexed

About

M.L. Williams is a scholar working on Molecular Biology, Organic Chemistry and Clinical Psychology. According to data from OpenAlex, M.L. Williams has authored 37 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Organic Chemistry and 10 papers in Clinical Psychology. Recurrent topics in M.L. Williams's work include Psychedelics and Drug Studies (10 papers), Chemical synthesis and alkaloids (8 papers) and Bacterial Genetics and Biotechnology (6 papers). M.L. Williams is often cited by papers focused on Psychedelics and Drug Studies (10 papers), Chemical synthesis and alkaloids (8 papers) and Bacterial Genetics and Biotechnology (6 papers). M.L. Williams collaborates with scholars based in Australia, United Kingdom and United States. M.L. Williams's co-authors include Will Lawn, Monica J. Barratt, Adam Winstock, A. J. Horne, Jill E. Gready, Paul Liknaitzky, M.J. Scanlon, Biswaranjan Mohanty, Brian J. Oldfield and Claire J. Foldi and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

M.L. Williams

34 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.L. Williams Australia	13	197	140	100	96	78	37	501
Garry R. Smith United States	16	56 0.3×	271 1.9×	146 1.5×	373 3.9×	113 1.4×	37	858
Tohru Kishi Japan	19	133 0.7×	129 0.9×	121 1.2×	78 0.8×	232 3.0×	43	802
Simon M. Bushell United States	11	58 0.3×	249 1.8×	160 1.6×	434 4.5×	139 1.8×	14	935
Alejandra Gallardo‐Godoy United States	15	44 0.2×	345 2.5×	119 1.2×	245 2.6×	12 0.2×	17	743
Charles F. Barfknecht United States	18	120 0.6×	308 2.2×	178 1.8×	210 2.2×	43 0.6×	62	858
Giuseppe Peluso Italy	9	42 0.2×	78 0.6×	19 0.2×	16 0.2×	72 0.9×	12	376
Eric T. Shimomura United States	12	23 0.1×	133 0.9×	45 0.5×	30 0.3×	151 1.9×	15	476
Ben Warner United Kingdom	8	75 0.4×	113 0.8×	214 2.1×	65 0.7×	8 0.1×	11	654
John T. Koh United States	19	98 0.5×	579 4.1×	141 1.4×	275 2.9×	8 0.1×	35	1.1k
Ronald K. Russell United States	16	55 0.3×	231 1.6×	17 0.2×	670 7.0×	27 0.3×	52	978

Countries citing papers authored by M.L. Williams

Since Specialization

Citations

This map shows the geographic impact of M.L. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Williams more than expected).

Fields of papers citing papers by M.L. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.L. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Williams. The network helps show where M.L. Williams may publish in the future.

Co-authorship network of co-authors of M.L. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of M.L. Williams. A scholar is included among the top collaborators of M.L. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.L. Williams. M.L. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, Margaret, Ravi Iyer, M.L. Williams, et al.. (2025). Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial. General Hospital Psychiatry. 96. 322–331. 1 indexed citations

Mohanty, Biswaranjan, Wesam S. Alwan, Menachem J. Gunzburg, et al.. (2025). Discovery of a Cryptic Pocket in Ec DsbA Opens New Opportunities for Antibacterial Discovery. Angewandte Chemie International Edition. 64(49). e202515306–e202515306.

Annan, Augustina, et al.. (2025). The impact of fecal microbiota transplantation on refractory ulcerative colitis: A systematic review and Meta-Analysis of randomised controlled trials. BMC Gastroenterology. 25(1). 654–654.

Doak, B.C., Kieran Rimmer, M.L. Williams, et al.. (2024). Fluoromethylketone‐Fragment Conjugates Designed as Covalent Modifiers of Ec DsbA are Atypical Substrates. ChemMedChem. 19(16). e202300684–e202300684. 3 indexed citations

Wang, Geqing, Biswaranjan Mohanty, M.L. Williams, et al.. (2022). Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials. ChemMedChem. 17(6). e202100673–e202100673. 4 indexed citations

Mohanty, Biswaranjan, Julien Orts, Geqing Wang, et al.. (2022). Methyl probes in proteins for determining ligand binding mode in weak protein–ligand complexes. Scientific Reports. 12(1). 11231–11231. 4 indexed citations

Williams, M.L., et al.. (2021). Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. Frontiers in Psychiatry. 12. 737738–737738. 14 indexed citations

Wang, Geqing, M.L. Williams, Wesam S. Alwan, et al.. (2020). Rapid Elaboration of Fragments into Leads by X-ray Crystallographic Screening of Parallel Chemical Libraries (REFiL_X). Journal of Medicinal Chemistry. 63(13). 6863–6875. 21 indexed citations

Alwan, Wesam S., M.L. Williams, B.C. Doak, et al.. (2020). NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide–dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei. Journal of Biomolecular NMR. 74(10-11). 595–611. 4 indexed citations

10.

Foldi, Claire J., Paul Liknaitzky, M.L. Williams, & Brian J. Oldfield. (2020). Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models. Frontiers in Neuroscience. 14. 43–43. 40 indexed citations

11.

Patil, Rahul, Biswaranjan Mohanty, Indu R. Chandrashekaran, et al.. (2019). A ligand-induced structural change in fatty acid–binding protein 1 is associated with potentiation of peroxisome proliferator–activated receptor α agonists. Journal of Biological Chemistry. 294(10). 3720–3734. 19 indexed citations

12.

Bright, Stephen & M.L. Williams. (2018). Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research. Australian Psychologist. 53(6). 467–476. 8 indexed citations

13.

Mohanty, Biswaranjan, Shakeel Mowlaboccus, Jason J. Paxman, et al.. (2018). Structural and biochemical insights into the disulfide reductase mechanism of DsbD, an essential enzyme for neisserial pathogens. Journal of Biological Chemistry. 293(43). 16559–16571. 6 indexed citations

14.

Mohanty, Biswaranjan, et al.. (2017). HN, N, Cα and Cβ assignments of the two periplasmic domains of Neisseria meningitidis DsbD. Biomolecular NMR Assignments. 11(2). 181–186. 1 indexed citations

15.

Williams, M.L., et al.. (2017). Purification and characterization of adenovirus core protein VII: a histone-like protein that is critical for adenovirus core formation. Journal of General Virology. 98(7). 1785–1794. 6 indexed citations

16.

Mohanty, Biswaranjan, M.L. Williams, B.C. Doak, et al.. (2016). Determination of ligand binding modes in weak protein–ligand complexes using sparse NMR data. Journal of Biomolecular NMR. 66(3). 195–208. 13 indexed citations

17.

Patil, Rahul, J. Wielens, Stephen J. Headey, et al.. (2014). Characterization of Two Distinct Modes of Drug Binding to Human Intestinal Fatty Acid Binding Protein. ACS Chemical Biology. 9(11). 2526–2534. 27 indexed citations

18.

Adams, Luke A., Pooja Sharma, Biswaranjan Mohanty, et al.. (2014). Application of Fragment‐Based Screening to the Design of Inhibitors of Escherichia coli DsbA. Angewandte Chemie International Edition. 54(7). 2179–2184. 45 indexed citations

19.

Williams, M.L., David K. Chalmers, Jennifer L. Martin, & M.J. Scanlon. (2009). Backbone and side chain 1H, 15N and 13C assignments for the oxidised and reduced forms of the oxidoreductase protein DsbA from Staphylococcus aureus. Biomolecular NMR Assignments. 4(1). 25–28. 2 indexed citations

20.

Williams, M.L., et al.. (1997). Charge collection efficiency and current pulses in GaAs detectors. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 395(1). 9–12. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact